Secondary Prevention of Recurrent Stroke
نویسندگان
چکیده
منابع مشابه
Secondary prevention of recurrent stroke.
Risk of Recurrent Stroke The risk of stroke after a transient ischemic attack (TIA) or mild ischemic stroke was 10% within 1 week and 18% within the first 3 months in Oxfordshire, UK, in 2002 to 2003.1 This substantial early risk is 3-fold higher if the TIA or ischemic stroke is caused by large artery disease and 5-fold lower if the cause is small artery disease.2 The prevalence and level of ot...
متن کاملPrevention of recurrent stroke.
Victims of atherothrombotic infarction of the brain, the most common variety of stroke, frequently have recurrent strokes. Risk factors believed to accelerate such events include hypertension, diabetes mellitus, hyperlipidemia, atherosclerotic disease (of heart, aortocervical and intracranial vessels), erythrocythemia, stress, tobacco smoking, hyperuricemia, and perhaps obesity. Most prior stud...
متن کاملSecondary prevention of stroke.
Stroke has been defined as a rapid onset of focal neurological deficit lasting more than 24 hours, with no apparent cause other than disruption of the blood supply to the brain (World Health Organization, 1989). A transient ischaemic attack (TIA) refers to a similar presentation that resolves within 24 hours (Hankey and Warlow, 1994). Approximately 15% of strokes are haemorrhagic, with the rest...
متن کاملRecurrent Ischemic Stroke Characteristics and Assessment of Sufficiency of Secondary Stroke Prevention.
INTRODUCTION Disabilities due to stroke lead to a serious individual and socioeconomic burden. In this presented hospital-based study, we aimed to evaluate recurrent ischemic stroke (RIS) characteristics and the sufficiency of secondary prevention regarding the most common modifiable risk factors. METHODS The records of patients with a diagnosis of ischemic stroke between November 2009 and No...
متن کاملPrevention of Recurrent Ischemic Stroke
The Warfarin-Aspirin Recurrent Stroke Study : For stroke patients with no atrial fibrillation or symptomatic carotid stenosis, the long-standing argument whether the success of warfarin with atrial fib rillation would show comparable effects for those without obvious cardiogenic stroke risk factors is better understood with the recent publication of the Warfarin Aspirin Recurrent Stroke Study (...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2005
ISSN: 0039-2499,1524-4628
DOI: 10.1161/01.str.0000153048.87248.3b